Halting the Epidemic of Addiction and Loss Act of 2025

Hozzl · 2025-08-01T03:53:19Z

Explore the details of Senate Bill 2336 Halting the Epidemic of Addiction and Loss Act of 2025 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on undefined. Stay informed on legislative developments.

8/1/2025, 3:53 AM

Summary of Bill S 2336

This bill aims to expand the scope of opioid overdose reversal agents mentioned in specific Department of Health and Human Services grant programs beyond just naloxone. Introduced in the 119th Congress as S. 2336 on July 17, 2025, the bill seeks to ensure that references to such agents are not restricted solely to naloxone, potentially broadening the types of medications or treatments eligible for consideration in relevant grant initiatives.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 2336

Bill S 2336 is currently in the status of Bill Introduced since July 17, 2025. Bill S 2336 was introduced during Congress 119 and was introduced to the Senate on July 17, 2025. Bill S 2336's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of July 17, 2025

Bipartisan Support of Bill S 2336

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 2336

Primary Policy Focus

Alternate Title(s) of Bill S 2336

A bill to ensure references to opioid overdose reversal agents in certain grant programs of the Department of Health and Human Services are not limited to naloxone.